title: Inverted takotsubo cardiomyopathy in a patient with essential thrombocythemia exposed to anagrelide and phentermine.
authors.forename: Artur
authors.initials: A
authors.lastname: Dziewierz
authors.forename: Agnieszka
authors.initials: A
authors.lastname: Olszanecka
authors.forename: Jerzy
authors.initials: J
authors.lastname: Wiliński
authors.forename: Tomasz
authors.initials: T
authors.lastname: Rakowski
authors.forename: Paweł
authors.initials: P
authors.lastname: Kleczyński
authors.forename: Jacek S
authors.initials: JS
authors.lastname: Dubiel
authors.forename: Dariusz
authors.initials: D
authors.lastname: Dudek
mesh_terms: D000328:Adult; D001067:Appetite Depressants / Q000009:adverse effects*; D005260:Female; D006801:Humans; D010645:Phentermine / Q000009:adverse effects*; D010975:Platelet Aggregation Inhibitors / Q000009:adverse effects* / Q000627:therapeutic use; D011799:Quinazolines / Q000009:adverse effects* / Q000627:therapeutic use; D054549:Takotsubo Cardiomyopathy / Q000139:chemically induced*; D013920:Thrombocythemia, Essential / Q000188:drug therapy
chemical_list: D001067:Appetite Depressants; D010975:Platelet Aggregation Inhibitors; D011799:Quinazolines; D010645:Phentermine; C021139:anagrelide